Boltwood Capital Management Buys Alexion Pharmaceuticals Inc, Tapestry Inc, Dow Inc, Sells DuPont de Nemours Inc, DuPont de Nemours Inc, Starbucks Corp

• New Purchases: ALXN, TPR, DOW,
• Added Positions: SCHE, CORP, AGN, CVS, KLAC, SCHF, ABC, CTSH, MCHP, XLRE, SCHM, SCHA, HACK, ZBH, SLB, GNR, MUB, UPS, BMY, HYG, AMT, MAS, SCHW, HAL,
• Reduced Positions: DD, DD, SBUX, VFC, XLV, RHT, LOW, PG, KO, INTC, DUK, D, COST, NEE, CVX, MDLZ, SCHB, APD, AVGO, IJH, DLTR, JEC, TJX, UNP, XLU, AMZN, CSCO, ICE, LQD, XLY, WMT, JPM, XLP, SPY, SUB, RWO, T, HD, VZ, XRX, VTI, XLF, VIG, XLE, MCO, BAC,
• Sold Out: BIIB,

For the details of Boltwood Capital Management's stock buys and sells, go to https://www.gurufocus.com/guru/boltwood+capital+management/current-portfolio/portfolio

1. Schwab International Equity (SCHF) - 220,737 shares, 4.51% of the total portfolio. Shares added by 2.12%
2. Chevron Corp (CVX) - 35,792 shares, 2.84% of the total portfolio. Shares reduced by 1.65%
3. Vanguard FTSE All World Ex US (VEU) - 85,296 shares, 2.77% of the total portfolio. Shares reduced by 0.02%
4. iShares Core S&P Small-Cap (IJR) - 50,910 shares, 2.54% of the total portfolio. Shares reduced by 0.88%
5. iShares Core S&P Mid-Cap (IJH) - 20,287 shares, 2.51% of the total portfolio. Shares reduced by 1.1%

Boltwood Capital Management initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $113.68 and $141.3, with an estimated average price of $128.81. The stock is now traded at around $131.27. The impact to a portfolio due to this purchase was 0.59%. The holding were 7,030 shares as of .

Boltwood Capital Management initiated holding in Tapestry Inc. The purchase prices were between $28.36 and $34.45, with an estimated average price of $31.18. The stock is now traded at around $31.29. The impact to a portfolio due to this purchase was 0.55%. The holding were 27,330 shares as of .

Boltwood Capital Management initiated holding in Dow Inc. The purchase prices were between $46.76 and $59.71, with an estimated average price of $52.82. The stock is now traded at around $50.16. The impact to a portfolio due to this purchase was 0.19%. The holding were 5,984 shares as of .

Boltwood Capital Management added to a holding in Allergan PLC by 25.88%. The purchase prices were between $115.73 and $167.43, with an estimated average price of $138.45. The stock is now traded at around $167.72. The impact to a portfolio due to this purchase was 0.11%. The holding were 4,985 shares as of .

Boltwood Capital Management added to a holding in CVS Health Corp by 32.38%. The purchase prices were between $52.13 and $57.33, with an estimated average price of $53.82. The stock is now traded at around $54.93. The impact to a portfolio due to this purchase was 0.1%. The holding were 12,020 shares as of .

Boltwood Capital Management added to a holding in KLA-Tencor Corp by 20.96%. The purchase prices were between $101.78 and $128.47, with an estimated average price of $115.59. The stock is now traded at around $121.73. The impact to a portfolio due to this purchase was 0.09%. The holding were 6,895 shares as of .

Boltwood Capital Management added to a holding in Schwab U.S. Mid Cap by 23.03%. The purchase prices were between $53.41 and $57.55, with an estimated average price of $56.11. The stock is now traded at around $57.43. The impact to a portfolio due to this purchase was 0.04%. The holding were 5,475 shares as of .

Boltwood Capital Management sold out a holding in Biogen Inc. The sale prices were between $219.29 and $241.72, with an estimated average price of $230.78.